finance
Most Read
In another sign of RNA’s growing popularity, the cancer startup Replicate is relaunching
Cityblock Health raises another mega-round of funding, tipping its valuation over $5 billion
Flagship, Orbimed, ARCH, Alta top list of high-performing biotech venture capital firms
The novel coronavirus is a serious threat. We need to prepare, not overreact
Pharma’s tarnished reputation helps fuel the anti-vaccine movement
STAT+ Conversation: Which biotech venture capital funds performed best during the pandemic?
